BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,478 | -15.1% | 39,166 | +2.5% | 0.01% | -16.7% |
| Q2 2023 | $1,741 | -23.4% | 38,222 | -31.8% | 0.01% | -20.0% |
| Q1 2023 | $2,274 | -20.1% | 56,070 | +0.4% | 0.02% | -28.6% |
| Q4 2022 | $2,847 | -99.9% | 55,851 | -29.7% | 0.02% | -32.3% |
| Q3 2022 | $4,277,000 | -52.8% | 79,402 | -43.7% | 0.03% | -49.2% |
| Q2 2022 | $9,064,000 | -78.8% | 141,112 | -74.4% | 0.06% | -72.1% |
| Q1 2022 | $42,704,000 | -8.4% | 550,731 | +1.4% | 0.22% | +4.8% |
| Q4 2021 | $46,638,000 | +100.5% | 543,314 | +87.9% | 0.21% | +65.9% |
| Q3 2021 | $23,261,000 | +5.4% | 289,211 | +5.5% | 0.13% | +3.3% |
| Q2 2021 | $22,074,000 | +348.3% | 274,211 | +369.7% | 0.12% | +351.9% |
| Q1 2021 | $4,924,000 | -43.5% | 58,381 | -46.2% | 0.03% | -49.1% |
| Q4 2020 | $8,712,000 | +14.8% | 108,570 | +15.0% | 0.05% | +8.2% |
| Q3 2020 | $7,589,000 | -61.3% | 94,370 | -58.6% | 0.05% | -69.4% |
| Q2 2020 | $19,620,000 | -12.3% | 227,870 | -17.3% | 0.16% | -33.3% |
| Q1 2020 | $22,379,000 | -22.3% | 275,637 | -20.0% | 0.24% | +6.2% |
| Q4 2019 | $28,816,000 | +2.9% | 344,609 | +7.7% | 0.23% | -7.8% |
| Q3 2019 | $27,993,000 | +78.8% | 320,028 | +67.4% | 0.24% | +88.5% |
| Q2 2019 | $15,660,000 | -32.7% | 191,210 | -33.1% | 0.13% | -34.7% |
| Q1 2019 | $23,256,000 | -11.2% | 286,014 | -28.1% | 0.20% | -18.8% |
| Q4 2018 | $26,176,000 | -23.6% | 397,684 | -10.5% | 0.24% | +2.5% |
| Q3 2018 | $34,248,000 | -46.2% | 444,255 | -48.4% | 0.24% | -40.8% |
| Q2 2018 | $63,607,000 | +37.2% | 861,416 | +20.9% | 0.40% | +29.5% |
| Q1 2018 | $46,353,000 | -4.5% | 712,679 | -5.1% | 0.31% | -3.7% |
| Q4 2017 | $48,535,000 | +64.5% | 750,850 | +59.7% | 0.32% | +79.0% |
| Q3 2017 | $29,508,000 | -10.0% | 470,253 | -13.2% | 0.18% | -19.9% |
| Q2 2017 | $32,786,000 | +3.3% | 541,563 | -11.5% | 0.23% | -0.4% |
| Q1 2017 | $31,747,000 | -6.3% | 612,164 | -19.9% | 0.23% | -7.0% |
| Q4 2016 | $33,883,000 | -5.4% | 764,159 | +1.5% | 0.24% | -2.8% |
| Q3 2016 | $35,835,000 | +229.1% | 752,845 | +212.7% | 0.25% | +239.2% |
| Q2 2016 | $10,888,000 | +580.9% | 240,771 | +518.7% | 0.07% | +572.7% |
| Q1 2016 | $1,599,000 | +88.6% | 38,914 | +75.1% | 0.01% | +83.3% |
| Q4 2015 | $848,000 | -31.8% | 22,229 | -41.3% | 0.01% | -40.0% |
| Q3 2015 | $1,243,000 | -82.2% | 37,848 | -62.0% | 0.01% | -80.8% |
| Q2 2015 | $6,972,000 | +64.4% | 99,695 | +61.0% | 0.05% | +57.6% |
| Q1 2015 | $4,241,000 | -2.5% | 61,907 | +4.4% | 0.03% | -2.9% |
| Q4 2014 | $4,348,000 | +62.1% | 59,324 | +58.7% | 0.03% | +54.5% |
| Q3 2014 | $2,683,000 | -3.6% | 37,379 | -2.9% | 0.02% | -4.3% |
| Q2 2014 | $2,782,000 | +13.5% | 38,478 | +15.5% | 0.02% | +4.5% |
| Q1 2014 | $2,451,000 | +262.0% | 33,305 | +242.4% | 0.02% | +266.7% |
| Q4 2013 | $677,000 | -97.1% | 9,728 | -97.3% | 0.01% | -97.1% |
| Q3 2013 | $23,598,000 | -11.3% | 359,239 | -6.5% | 0.21% | -14.8% |
| Q2 2013 | $26,616,000 | – | 384,242 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |